Used in nearly all stages of drug development (from discovery to preclinical and clinical research), QIAGEN DiseaseLand encompasses multi-omics data, while providing a standardized pipeline for incorporation of data, with controlled vocabularies for associated information.
- Utilize public single-cell RNA-seq data
- Broad support for genomic data types and thousands of curated and quality-controlled public disease-focused genome datasets
- Powerful visualization and analytics to compare and correlate within and across datasets
- Internal “Land” next-generation database technology provides very fast access to a large number of genomic datasets